INTRODUCTION
The hematopoietic system consists of multiple blood cell lineages that are derived from pluripotential hematopoietic stem cells (HSCs) and multipotential and lineage-committed progenitor (LCP) cells. The maintenance of stem cells, which depends on the balance between quiescence, proliferation, and differentiation of cells, requires interactions with special microenvironments, termed niches (Adams and Scadden, 2006; Kiel and Morrison, 2008; Kincade et al., 1998; Li and Xie, 2005; Moore and Lemischka, 2006; Suda et al., 2005) . In the developing mouse, HSCs arise in the yolk sac, the placenta, and the aorta-gonad-mesonephros region. Later, they are found predominantly in the fetal liver as the major site of hematopoiesis (Mikkola and Orkin, 2006) . Before birth, HSCs are translocated via the peripheral circulation to the developing bone marrow, in which a subpopulation of bone-forming osteoblasts, termed spindle-shaped, N-cadherin-positive osteoblasts (SNO), has been implicated in constituting a niche for HSCs (Calvi et al., 2003; Zhang et al., 2003) . Osteoblasts have been found to secrete factors that regulate the homeostasis of HSCs, including angiopoietin, which promotes the maintenance of quiescent HSCs (Arai et al., 2004) , and the chemokine CXCL12 (Sugiyama et al., 2006) , which mediates stem cell trafficking.
In addition to the endosteal niche, perivascular cells and mesenchymal progenitors are in contact with HSCs and have been found to secrete angiopoietin and CXCL12 (Arai et al., 2004; Kiel et al., 2005; Sacchetti et al., 2007; Sugiyama et al., 2006) . Both osteoblastic and endothelial cells can promote the maintenance of HCSs in culture, and both stromal cell types influence each other, which makes it difficult to attribute specific functions to the endosteal and perivascular niches (Kiel and Morrison, 2008) . Moreover, a significant number of HSCs are not localized adjacent to the endosteum and sinusoids, suggesting that additional cells, including adiponectin-secreting adipocytes, may contribute to the maintenance of HSCs in vivo (DiMascio et al., 2007; Kiel et al., 2005) . In contrast to the stem cell niches that regulate the self-renewal and quiescence of HSCs, other cellular microenvironments support the differentiation of stem cells into specific hematopoietic lineages, such as the B lymphocyte lineage (Tokoyoda et al., 2004) .
In addition to cytokines and growth factors, Wnt signaling has been implicated in the self-renewal of HSCs and the expansion of lineage-committed progenitor cells (Malhotra and Kincade, 2009; Staal et al., 2008) . The role of Wnt signaling in the homeostasis of HSCs is complex because it involves the interplay between canonical and noncanonical Wnt signaling pathways and antagonists (Malhotra et al., 2008; Malhotra and Kincade, 2009) . The canonical Wnt pathway is initiated by binding of a subgroup of Wnt proteins, including Wnt3a, to Frizzled receptors and Lrp5/6 coreceptors. As a consequence, b-catenin accumulates and localizes to the nucleus where it associates with members of the Lef1/Tcf family of transcription factors and regulates the expression of target genes . Noncanonical Wnt signaling, which is initiated by a different group of Wnt proteins including Wnt5a, does not result in b-catenin stabilization, but it can antagonize canonical Wnt signaling (Murdoch et al., 2003; Nemeth et al., 2007) . The functions of Wnt proteins in hematopoiesis can also be modulated by secreted antagonists. In particular, Dickkopf (Dkk) proteins, which bind to the Lrp5/6 coreceptors, have been found to modulate Wnt signaling in stem cell maintenance (Fleming et al., 2008) . Moreover, secreted Frizzled-related proteins (Sfrps) bind Wnt ligands and prevent the activation of the Frizzled receptors (Bovolenta et al., 2008) . Wnt proteins and their antagonists have been found to be expressed by stromal cells and HSCs, suggesting that HSCs may use the Wnt signaling pathways in an autocrine and paracrine manner (Austin et al., 1997; Hackney et al., 2002; Phillips et al., 2000) .
In contrast to the extensively studied roles of signaling pathways in HSC homeostasis, much less is known about the function of transcription factors in this process. Early B cell (Ebf) proteins represent a small family of highly conserved transcription factors that include the founding member Ebf1, which is expressed in B lymphocytes, osteoblasts, and adipocytes and acts as a determinant of the B cell lineage (Hagman et al., 1993; Jimenez et al., 2007; Lin and Grosschedl, 1995; Medina et al., 2004) . Another member of the family, Ebf2, is not expressed in B lymphocytes, but is expressed more abundantly in immature osteoblastic cells, adipocytes, and neurons (Garel et al., 1997; Kieslinger et al., 2005; Malgaretti et al., 1997) . The expression of Ebf2 in immature osteoblastic cell raised the question of whether this transcription factor plays a role in the stromal support of hematopoiesis.
RESULTS

Ebf2 Is Expressed in Bone Marrow Stromal Cells and Required for Normal Hematopoiesis
Ebf2 is expressed in immature osteoblastic cells of the bone marrow (Kieslinger et al., 2005) . To further characterize the expression of Ebf2 at sites of hematopoiesis, we performed RT-PCR and detected Ebf2 transcripts at low levels in bone marrow (BM) and spleen ( Figure 1A ). In the thymus, the level of Ebf2 was higher and resembled that observed in brain as a positive control ( Figure 1A ). To visualize Ebf2-expressing cells in lymphoid organs, we measured b-galactosidase (lacZ) activity in tissue sections of Ebf2 +/À mice, carrying one allele of an in-frame insertion of the lacZ gene into the Ebf2 locus that abrogates protein expression from the mutant allele (Corradi et al., 2003) . This analysis identified a small population of lacZpositive cells at the boundary between cortex and medulla of the thymus and in the red pulp and marginal zone of the spleen (Figures S1A and S1B available online). To examine whether Ebf2 is expressed in hematopoietic cells, we sorted cells from bone marrow, spleen, and thymus that are positive for the pan-hematopoietic marker CD45 and analyzed the presence of Ebf2 transcripts by RT-PCR. Ebf2 transcripts were detected neither in RNA from CD45-positive cells nor in RNA from sorted HSCs and common lymphoid progenitors (CLP; Figure 1A ).
Ebf2-expressing cells represent immature osteoblastic cells because they contain abundant transcripts of Runx2, express Sox9 at a low level, and lack detectable transcripts of Osteocalcin (Kieslinger et al., 2005) . To examine whether Ebf2 is also expressed in the bone marrow vasculature, which has been implicated in the function of hematopoietic niches (Kiel and Morrison, 2008; Kiel et al., 2005) , we isolated adherent cells from the long bones of Ebf2 +/À mice and prepared RNA from cells that have been sorted as positive or negative for the expression of Ebf2-lacZ. Quantitative RT-PCR analysis showed a similar expression of CD31 (PECAM-1), a marker of endothelial cells, in Ebf2-lacZ-positive and -negative cells ( Figure 1B) . In Ebf2-lacZpositive cells, the levels of Angiopoietin (Ang-1) and N-cadherin were 4-and 20-fold higher, respectively ( Figure 1B) . By flow cytometry, we found that N-cadherin is expressed in a small subpopulation of Ebf2-lacZ-positive cells ( Figure 1C ). MECA-32, a marker for endothelial cells that are located in close proximity to immature hematopoietic cells (Kiel et al., 2005) , was detected in a subpopulation of Ebf2-negative, but not in Ebf2-lacZ-positive, cells ( Figure 1D ). Thus, Ebf2 is expressed in immature osteoblastic cells of the bone marrow that include a small subpopulation of N-cadherin-expressing cells, but not in endothelial or hematopoietic cells.
Impaired Lymphopoiesis in the Absence of Ebf2
Flow cytometry analysis to detect B220 + CD43 + pre-B cells and B220 + CD43 À B cells in 3-week-old mice indicated that both cell populations are markedly reduced in Ebf2 À/À mice ( Figure 1E ). In addition, the total number of thymocytes in 3-week-old Ebf2 À/À mice was reduced $6-fold, whereby the frequency of CD4 + CD8 + double-positive cells was decreased relative to the frequencies of mature CD4 + and CD8 + single-positive cells ( Figure 1F ). The analysis of markers of cells in the myeloid, granulocytic, erythroid, and NK lineages did not reveal any significant changes in the mutant mice ( Figure S1C and data not shown). To determine whether the observed lymphoid defects in Ebf2 À/À mice are due to changes in the stromal environments of hematopoietic cells, we performed adoptive transfer experiments of Ebf2 À/À bone marrow into lethally irradiated C57Bl/6 mice. In this experiment, we could distinguish Ebf2 À/À and Ebf2 +/+ cells by the expression of the surface markers CD45.2 and CD45.1, respectively. 3 to 4 months after transplantation, the B cell populations in the bone marrow and the thymic cell populations were similar in mice that have been reconstituted with wild-type or mutant bone marrow ( Figures  1G and 1H) . Thus, the defects in lymphopoiesis in Ebf2 À/À mice are due to defects in the stromal environment. Expression of Ebf2 could not be detected in the fetal liver, and flow cytometric analysis of fetal B and T lymphopoiesis did not reveal any significant defects in Ebf2 À/À mice ( Figure S1D and data not shown). We also determined the cellularities of hematopoietic cells in the bone marrow, spleen, and thymus of wild-type and mutant mice between 2 and 6 weeks after birth, before the mice die for unknown reasons. In 3-week-old Ebf2 À/À mice, which are still healthy and have normal weight, we detected an approximately 2-fold decrease of hematopoietic cells in the bone marrow relative to wild-type mice and almost 6-fold decrease in both spleen and thymus ( Figure 1I ). Therefore, the stromal defects concern the adult, but not fetal, sites of hematopoiesis.
Reduced Numbers of Lineage-Committed Progenitors and HSCs in Ebf2 -/-Mice
To determine the frequencies of lineage-committed progenitors in Ebf2 À/À bone marrow, we performed colony-forming assays under conditions that detect precursors of various lineages.
In the mutant bone marrow, we observed a modest but reproducible reduction of the frequencies of erythroid progenitors (CFU-E: 26%; BFU-E: 63%) and granulocytic/myeloid progenitors (CFU-GM: 32%; CFU-M: 26%; CFU-G: 65%) relative to wild-type bone marrow ( Figure 2A ). However, the frequency of B cell progenitors was reduced by a factor of 3. We also examined the frequencies of hematopoietic progenitor cells that can reconstitute all lineages in a competitive bone marrow repopulation assay by injecting mutant or wild-type cells at four dilutions (1 3 10 4 to 3 3 10 5 ) into sublethally irradiated mice that retain endogenous hematopoietic progenitors (Calvi et al., 2003; Zhang et al., 2003) . In this experiment, in which we also monitored the engraftment over time, we observed a 2-fold decrease in the number of long-term reconstitution units in the mutant versus wild-type bone marrow ( Figure 2B ; Figure S2A ). Akashi et al., 2000) , were relatively unaffected ( Figures 2C and 2D) .
To extend our analysis to hematopoietic stem cells, we analyzed HSCs by the surface expression of the SLAM cell surface markers CD244, CD150, and CD48 (Kiel et al., 2005) , by the retention/efflux properties of cells that have been loaded with Hoechst dye (Goodell et al., 1996) , and by the expression of CD150 and CD34 on KSL (c-kit Kim et al., 2007) . In 3-week-old Ebf2
mice, the frequency of HSCs presenting a fetal phenotype was found to be increased relative to that detected in wild-type mice, whereas the number of adult HSCs was decreased (Figures 2G and 2H) . No difference in the frequencies of fetal HSC was observed in the fetal liver of E16.5 wild-type and Ebf2-deficient embryos ( Figure S2B ). Thus, the stromal defect in Ebf2 À/À mice appears to affect specifically the adult HSCs.
Role of Ebf2 in the Stromal Support of HSCs In Vitro
Osteoblastic cells of the bone marrow have been implicated in the generation of a niche that supports the maintenance of HSCs in vivo (Calvi et al., 2003; Lo Celso et al., 2009; Xie et al., 2009; Zhang et al., 2003) . To examine whether immature hematopoietic cells and Ebf2-expressing osteoblastic cells are in close contact, we performed immunohistochemistry on sections of femurs of E18.5 wild-type and Ebf2 À/À mice ( Figure 3A ). In the trabecular bone region, Ebf2-lacZ-expressing immature osteoblastic cells (green) that line the bone matrix were detected in close proximity to Sca1-expressing hematopoietic progenitor cells (red), which include HSCs and cells representing earliest stages of differentiation. Inactivation of the Ebf2 gene results in changes of the architecture of trabecular bone that include a decrease in mineral bone density and an increase in osteoblast-mediated differentiation of osteoclasts (Kieslinger et al., 2005) . To examine whether Ebf2-deficient osteoblastic cells have a functional defect in the maintenance of HSCs in vitro, we incubated Ebf2 +/À or Ebf2 À/À osteoblastic cells that have been sorted for Ebf2-lacZ expression (Kieslinger et al., 2005) with wildtype HSC-enriched KSL cells. The sorted KSL cells were cocultured for 10 days in serum-free medium, supplemented with low amounts of IL3, IL6, and SCF, and examined for the formation of cobblestone areas (CA). CA colonies have been suggested to derive from stem cells, and they have been proposed to represent a primitive transplantable stem cell compartment (Moore et al., 1997; Ploemacher et al., 1991) . In coculture with Ebf2 À/À osteoblastic cells, we observed a 45% reduction in CA colonies, relative to cocultures with Ebf2 +/À cells ( Figures  3B and 3C ). To further characterize the cells that form cobblestone areas, we transferred cells from the cocultures into methylcellulose medium and determined the ability of the cells to give rise to colonies containing more than 50 cells after 5 days. The CA assay indicated that approximately 5.6 of 1000 cells have the ability to form colonies in coculture with Ebf2 +/À osteoblastic cells, whereas this frequency was reduced to 3.1 of 1000 cells in coculture with Ebf2 À/À cells ( Figure 3D ). Figure 3E ).
Ebf2 Augments HSC Maintenance In Vitro and Acts Redundantly with Other Ebf Proteins
Few stromal cell lines have been shown to support HSCs and progenitors in vitro. In particular, the stromal cell lines AFT024 and 2018, which have been generated from fetal liver by immortalization with SV40 T-antigen, support in vitro maintenance of HSCs with high and low efficiency, respectively (Moore et al., 1997) . Microarray analysis aimed at detecting differences in the expression of genes that may be involved in the support of HSCs indicated that Ebf2 is differentially expressed in AFT024 and 2018 (Hackney et al., 2002) . Quantitative RT-PCR indicated that the level of Ebf2 expression in AFT024 cells is 20-fold higher than that in 2018 cells ( Figure 4A ). To examine whether the forced expression of Ebf2 in 2018 cells would augment the in vitro maintenance of cocultured HSCs, we transduced 2018 cells with an Ebf2-GFP bicistronic retrovirus and performed an immunoblot analysis to determine Ebf protein expression and a CA assay to measure the stromal support ( Figure 4B , upper and lower panels). In coculture with Ebf2-transduced 2018 cells, we observed a 2-to 3-fold increase in the formation of CA colonies relative to mock-transduced 2018 cells ( Figure 4B ; lower panel). However, we did not obtain the efficiency observed with AFT024 cells, which was found to be similar to Ebf2-lacZpositive osteoblastic cells ( Figure 4C and data not shown). Ebf2 is highly conserved with three other members of the Ebf family of transcription factors (Dubois and Vincent, 2001 ) and therefore, we also examined the potential of Ebf1 and Ebf3 to augment the stromal support of 2018 cells. Forced expression of Ebf1 or Ebf3, which was detected by a monoclonal antibody that recognizes all members of the Ebf family (a-panEbf), also resulted in an increase in the stromal support of HSC-enriched KSL cells by 2018 cells ( Figure 4B ). In contrast, overexpression of Ebf1 or Ebf2 did not result in an increase in the stromal support by AFT024 cells, whereas Ebf3 overexpression resulted in a modest decrease of the stromal support ( Figure 4C ). 
Redundancy of Ebf Proteins in the Stromal Support of HSCs
The modest defect of Ebf2 À/À osteoblastic cells in supporting hematopoiesis in vivo and in vitro raised the question of whether Ebf2 acts redundantly with other members of the Ebf family; Ebf1 and Ebf3 transcription factors are also expressed in Ebf2-positive osteoblastic cells (Kieslinger et al., 2005) . The inactivation of Ebf1 results in a perinatal death, preventing the analysis of Ebf1
Ebf2
À/À osteoblasts. Therefore, we generated a GFP retroviral construct that allows for the concomittant expression of Ebf1-, Ebf2-, and Ebf3-specific siRNAs, with the RNAi flanking region of miR155 ( Figure 4D ; Chung et al., 2006) . We generated different siRNA constructs and found that two constructs, termed RNAi-a and RNAi-b, downregulated total Ebf protein Figures 4E-4G ). In these experiments, siRNA construct b was more efficient in the downregulation of Ebf proteins than construct a. In a CA assay, we found that the transduction of sorted Ebf2 +/À lacZ-positive osteoblasts with the siRNA b construct reduced the stromal support of HSC-enriched KLS cells by a factor of 4 ( Figure 4E ). We also examined the effects of siRNA-mediated combined downregulation of Ebf protein expression in Ebf2 À/À lacZ-positive osteoblasts and observed a stronger decrease in the stromal support of HSC-enriched KSL cells than that observed with knockdown of Ebf1 or Ebf3 alone ( Figure 4F ). Moreover, the combined knockdown of Ebf1, Ebf2, and Ebf3 in AFT024 cells impaired stromal support by a factor of 4 to 5 ( Figure 4G ). Transduction of 2018 cells with the siRNA construct affected only modestly the formation of CA colonies (data not shown). Taken together, these results suggest that Ebf proteins act redundantly in the support of immature hematopoietic cells in vitro and that the expression of Ebf proteins is an important, but not sufficient, determinant in this process.
Identification of Ebf2 Target Genes
With the aim of identifying genes that are differentially expressed in Ebf2 +/À and Ebf2 À/À osteoblasts, we sorted these cells for lacZ expression and performed a microarray analysis.
In Ebf2 À/À cells, several genes were found to be down-or upregulated by more than 4-fold, as compared to Ebf2 +/À cells (Table S1 ). Among the downregulated genes, we identified Proliferin, encoding a secreted ligand of the insulin-like growth factor receptor that has been implicated in the self-renewal of HSCs (Choong et al., 2003) . Additional downregulated genes included osteoprotegerin, encoding a RANK decoy receptor that we have previously identified as a direct target of Ebf2 in osteoblasts (Kieslinger et al., 2005) . Several genes were upregulated in Ebf2 À/À cells, including secreted frizzled-related proteins (Sfrp1 and Sfrp2; Table S1 ). To confirm and quantify the altered expression of these and other genes identified in the microarray analysis, we performed quantitative RT-PCR on three different osteoblastic cell preparations from Ebf2 +/À and Ebf2 À/À mice.
In Ebf2 À/À cells, the expression of Proliferin was reduced by a factor of 7, whereas the expression of Sfrp1 and Sfrp2 was increased 3.5-and 8-fold, respectively ( Figures 5A and 5B) . Moreover, we found that the forced expression of Ebf2 in 2018 cells augmented the expression of Proliferin 5.2-fold and reduced the expression of Sfrp1 and Sfrp2 by a factor of 3.1-and 9.6-fold, respectively ( Figure 5C ). Finally, we performed in situ hybridization and immunohistochemistry and found that the cells expressing these genes are localized immediately adjacent to the bone matrix ( Figure S3 ). 
Modulation of Wnt Signaling in HSCs by
Sfrp2-transduced Ebf2
À/À cells was reduced ( Figure 5D ).
We also determined the effects of forced expression of Ebf2, Proliferin, and Sfrp2 on the frequencies of colony-forming cells (CFU-C). The frequency of CFU-C in coculture with vector-transduced Ebf2 À/À osteoblastic cells was 3.8/1000 ( Figure 5E ). Figure 6A ). In Ebf2 À/À KLS cells, we also detected a modest 2-to 3-fold downregulation of the Notch1 and HoxB4 genes that have been previously implicated in the maintenance of HSCs (Reya et al., 2003 Figure 6B, top) . Thus, the defect of Ebf2 À/À osteoblastic cells may, at least in part, be accounted for by the upregulation of Sfrp genes and a decreased Wnt response in HSCs ( Figure 6C ).
DISCUSSION
Our study suggests that Ebf2 is required for the proper stromal support of hematopoietic progenitor cells in vivo and in vitro. Determination of the frequencies of HSCs by competitive reconstitutions and flow cytometric analysis indicated that Ebf2-deficient mice have a 2-to 4-fold decrease of the numbers of HSCs as compared to wild-type mice. In principle, the decrease in the numbers of HSCs in Ebf2 À/À bone marrow could be accounted for by distinct stromal defects, including the homing of cells to the bone marrow, cell adhesion, differentiation, and the balance of proliferation and quiescence. The observation that the potential to support HSCs in short-term coculture exper- iments is 2-fold lower in sorted Ebf2
osteoblastic cells, as compared to Ebf2 +/À cells, argues against a defect in homing. Moreover, the expression of CXCL12, which is involved in homing of progenitor cells (Hattori et al., 2003) , is normal in homozygous mutant osteoblastic cells (data not shown). Although the altered proliferation of HSC-enriched KSL cells and the reduced CAFC formation on Ebf2-deficient osteoblastic cells suggest a defect in the bone marrow niche of Ebf2 À/À mice, the CAFC assay does not necessarily reflect niche functions. Assessment of in vivo niche function would require a transfer of wild-type bone marrow cells into Ebf2
mice, which has not been possible because of their lethality between 6 and 8 weeks after birth. The expression of Ebf2 in stromal cells of the bone marrow but not fetal liver is consistent with the lack of a hematopoietic phenotype in fetal liver. Differences in fetal versus adult hematopoiesis involve not only stromal cells, but also the HSCs themselves (Kikuchi and Kondo, 2006) . Fetal and adult HSCs differ in their stem cell properties, reconstitution potential, and molecular markers (Kim et al., 2007 (Kim et al., , 2009 ). Interestingly, we found that the numbers of HSCs representing an adult surface phenotype are reduced in Ebf2-deficient bone marrow, whereas HSCs with a fetal phenotype are not affected. Therefore, the expression of Ebf2 in bone marrow stroma may affect the switch of fetal to adult HSCs.
We have previously shown that Ebf2-deficient long bones have an altered bone mass and trabecular structure, which can be accounted for by an increased number of bone-degrading osteoclasts and a downregulation of the expression of the RANK decoy receptor gene Opg in osteoblasts (Kieslinger et al., 2005) . However, the numbers of osteoblasts and the rate of bone formation were found to be normal in Ebf2 À/À mice (Kieslinger et al., 2005) . The bone defect in Ebf2-deficient mice may explain the reduced cellularity of the bone marrow, but it cannot account for the reduced stromal support of hematopoietic progenitors in vitro. Therefore, the Ebf2-deficient osteoblastic cells appear to have at least two functional defects, one related to the osteoblast-dependent differentiation of osteoclasts and the other related to the stromal support of hematopoietic progenitor cells. Interestingly, osteoblasts have been implicated in the support of hematopoietic progenitors through the production of secreted and membrane-bound growth factors (Suda et al., 2005; Taichman, 2005) . In particular, an increase in the numbers of osteoblastic cells in mice with a conditional inactivation of the bone-morphogenetic protein receptor (Bmpr-1a) or in mice overexpressing the parathyroid hormonerelated protein receptor parallels an increase in the numbers of HSCs (Calvi et al., 2003; Zhang et al., 2003) . Previous comparison of stromal cell lines that support or do not support HSC self-renewal revealed that Ebf2 transcripts are more abundant in the HSC-supporting cell line AFT024, relative to the nonsupporting line 2018 (Hackney et al., 2002) . Notably, we found that the forced expression of Ebf2 in 2018 cells augments their stromal support in CA assays. Although fetal stromal cells do not normally express Ebf2, the expression of Ebf2 in AFT024 cell line may be related to the transformation with SV40. In addition to the stromal cells in the bone marrow, we also detect Ebf2-lacZ expression in some as yet uncharacterized stromal cells of the spleen and thymus, which may account for the marked defect in these lymphoid compartments.
In our analysis of genes that are differentially expressed in osteoblastic cells from Ebf2 +/À and Ebf2 À/À mice, we identified
Proliferin as a downregulated gene in Ebf2-deficient cells. The Proliferin family of glycoproteins is related to the prolactin family of peptide hormones that act as ligands for insulin type II receptors and have cell growth-promoting activity (Choong et al., 2003) . Proliferin has been identified in a microarray screen for genes that are upregulated in stromal cell lines supporting immature hematopoietic cells, and it has been implicated in the ex vivo expansion of HSCs (Choong et al., 2003) . Consistent with these findings, Proliferin is not only downregulated in Ebf2-deficient osteoblastic cells, but its forced expression in Ebf2 À/À osteoblastic cells can influence their stromal activity in coculture with wild-type hematopoietic progenitor cells. In addition, we identified adiponectin as a gene that is upregulated in Ebf2
mice. Adiponectin, a protein that is secreted from adipocytes, has been recently identified as a factor involved in the support of HSCs (DiMascio et al., 2007) . Therefore, it is likely that Ebf2-expressing cells consist of several cell types, including cells of the osteoblast and adipocyte lineages, and possibly mesenchymal progenitor cells that support the maintenance of HSCs by different mechanisms. Another interesting set of target genes are the Srfp-1 and -2 genes, which are upregulated in Ebf2 À/À osteoblastic cells.
Both Sfrp proteins antagonize canonical and noncanonical Wnt signaling and thus modulate pathways implicated in the maintenance of HSCs (Bovolenta et al., 2008; Malhotra and Kincade, 2009; Staal et al., 2008; Fleming et al., 2008; Renstrom et al., 2009) . Although the role of the canonical Wnt pathway in the maintenance of hematopoietic cells has been extensively studied, various loss-and gain-of-function experiments of b-catenin did not yield reciprocal results (Austin et al., 1997; Baba et al., 2006; Duncan et al., 2005; Jeannet et al., 2008; Kirstetter et al., 2006; Koch et al., 2008; Murdoch et al., 2003; Reya et al., 2003; Scheller et al., 2006) . Moreover, the effects of Wnt signaling in hematopoiesis may be subtle because a deficiency of Wnt3a or a blockage of Wnt signaling by osteoblast-specific overexpression of a Dkk transgene reveals HSC defects only in secondary transplantations (Fleming et al., 2008; Luis et al., 2009 ). In the Dkk overexpression experiments, Wnt signaling was shown to regulate the quiescence of HSCs and the maintenance of the reconstitution function (Fleming et al., 2008) . A similar phenotype is observed in Sfrp1 À/À mice whereby engraftment is increased in primary recipients but decreased in secondary recipients (Renstrom et al., 2009) . Moreover, Sfrp1 À/À stromal cells are more efficient in the support of hematopoietic progenitors in vitro (Renstrom et al., 2009) . Sfrps act as negative regulators of both canonical and noncanonical Wnt signaling by binding directly to Wnt proteins and preventing their interaction with membrane-bound Frizzled receptors (Bovolenta et al., 2008) . However, the antagonistic function of Sfrps is context dependent; they can also act as Wnt agonists (Yokota et al., 2008 (Barolo, 2006) . Moreover, we find a downregulation of Notch1 in Ebf2 À/À HSCs, which is consistent with the reported upregulation of the Notch1 target Hes1 in Srfp1-deficient hematopoietic progenitors (Renstrom et al., 2009 ). However, Notch1 deficiency does not affect hematopoiesis (Maillard et al., 2008) . Therefore, we favor the view that the defect of hematopoiesis in Ebf2 À/À mice reflects, at least in part, a Sfrp-mediated alteration of Wnt signaling in the stromal compartment. Although the role of Wnt signaling in HSCs is still controversial, increasing evidence suggests a requirement of b-catenin in bone marrow stromal cells for the maintenance and adhesion of primitive hematopoietic cells (Kim et al., 2009; Nemeth et al., 2009) . The specific role of Ebf2 in adult hematopoiesis may also reflect differences in the responsiveness of fetal versus adult HSCs to the expression of various signaling agonists or antagonist that are regulated by Ebf2 and known to affect HSC homeostasis (Morrison et al., 1995; Phillips et al., 2000) . The Ebf protein family is highly conserved from C. elegans and Drosophila to mouse and man (Dubois and Vincent, 2001 ). The Drosophila ortholog of Ebf2, collier, has been recently implicated in the stromal support of hematopoiesis (Crozatier et al., 2004; Krzemien et al., 2007; Mandal et al., 2007) . A discrete cluster of cells in the Drosophila lymph gland, termed the posterior signaling center (PSC), expresses collier and has been proposed to resemble the stromal microenvironments in mammalian hematopoietic organs (Crozatier et al., 2004; Lebestky et al., 2003) . The PSC regulates the balance between the maintenance of quiescent prohemocytes and the differentiation of these cells into mature hemocytes, including macrophage-like plasmatocytes and lamellocytes. Notably, collier is required for hematopoiesis in a cell-nonautonomous manner, and it endows PSC cells with the capacity either to maintain hematopoietic progenitor cells and/or to induce their differentiation into lamellocytes (Krzemien et al., 2007; Mandal et al., 2007) . Therefore, the role of Ebf proteins in the stromal support of hematopoiesis may be evolutionary more ancient than the role of Ebf1 in the specification and differentiation of B lineage cells.
EXPERIMENTAL PROCEDURES
PCR, RT-PCR, and Quantitative RT-PCR Analysis of the Ebf2 mutation was carried out in the C57Bl/6 strain of mice; all animals used for this study were healthy and showed normal body weight. Genotyping of Ebf2 mutant animals was performed as described (Corradi et al., 2003) . RT-PCR was carried out according to standard protocols. Quantitative RT-PCR was performed with SYBR GREEN PCR master mix (Applied Biosystems) and the ABI PRISM 7000 sequence detection system. Sequences for primer pairs are presented in Supplemental Information. Three independent measurements were performed for each PCR analysis. The comparative CT method was used to calculate the expression levels of RNA transcripts, and the individual RNA expression levels were normalized to the expression of b-actin. Error bars represent the standard deviation of the mean of three experiments.
Isolation and Cultivation of Cells and Lentiviral and Retroviral Infection
Preparation of osteoblastic cells from embryonic and neonate bone was performed as described (Kieslinger et al., 2005) . For coculture experiments, cells were isolated under osteoblastic conditions from embryonic leg (E18.5) and 2000 cells were sorted as Ebf2-lacZ positive into each well of a 96-well plate. Cells were allowed to expand to 90% confluency, and sorted KSL (Lin À Sca1 hi c-kit hi ) immature hematopoietic cells were used for coculture under serum-free conditions (StemPro SFM, Invitrogen) in the presence of recombinant SCF (15 ng/ml), IL3 (5 ng/ml), and IL6 (5 ng/ml). Medium was partially changed twice a week. After 10 days of coculture, photomicrographs were taken and after 14 days cobblestone-area-forming cells were counted. To determine CFU-C activity, cells were isolated via trypsin, sorted for the expression of CD45, and seeded into methylcellulose medium (Arai et al., 2004) . After 10 days of culture, colony numbers were determined, and the frequencies of CFU-C/total cell number were calculated. Lentiviral infections of HSC with control or Wnt-responsive reporter viruses were performed as described (Reya et al., 2003) . For retroviral infections of osteoblastic cells, Ebf1, -2, or -3 were cloned into an MSCV-IRES-GFP retroviral vetor. Proliferin, Sfrp1, and Sfrp2 were cloned into a MSCV-irDsRed vector (gift of Kevin D. Bunting). LTC-IC assays were carried out as described (Choong et al., 2003; Ploemacher et al., 1991) , via sorted HSCs and sorted Ebf2-lacZ-expressing osteoblastic cells from Ebf2 +/À and Ebf2 À/À mice.
RNAi
For the downregulation of Ebf proteins by RNAi, the BLOCK-iT miR RNAi expression vector kit (Invitrogen) was used to clone short-hairpin DNA directed against the three Ebf genes into the vector pcDNA6.2-GW/EmGFP-miR. For the production of retroviruses, the IRES-GFP site of pMSCV was removed and the sequence containing the short hairpins plus the EmGfp were cloned into the pMSCV. The sequences used for the RNAi constructs are presented in Supplemental Information. Overexpression and downregulation of Ebf proteins were determined by immunoblot analysis with Ebf antibody (clone 6G6).
Statistics p values were determined with the Student's two-tailed t test for independent samples, assuming equal variances on all experimental data sets.
Generation of Bone Marrow Reconstituted Mice and Competitive Reconstitution CD45.1 (Ly5.1; Ptprc) C57Bl/6 mice were purchased from Jackson Labs (Boston, MA) and lethally irradiated with 960 rad, given as a split dose (Gammacell 40, MDS Nordion). Ebf2 +/+ and Ebf2 À/À bone marrow was isolated, and 500,000 cells were injected into the tail vein of irradiated host animals. Wild-type C57/Bl6 bone marrow cells and PBS were injected as positive and negative controls, respectively; in each case, five animals were used. Analysis was carried out between 3 to 4 months after injection, with CD45.2-specific antibodies to gate for donor-derived cells, because the Ebf2 mutation is in a CD45.2 (Ly5.2) C57Bl/6 background.
Competitive reconstitution was performed as described (Zhang et al., 2003) . In brief, CD45.1 C57Bl/6 mice were sublethally irradiated with a dose of 480 rad, and CD45.2-expressing bone marrow cells from Ebf2 +/+ and Ebf2 À/À mice were injected at four different concentrations (1 3 10 4 , 3 3 10 4 , 1 3 10 5 , 3 3 10 5 ) into the irradiated host animals. PBS was injected as negative control and WT C57Bl/6 bone marrow cells were injected at the given concentrations as positive control. In each case, five animals were used for the adoptive transfer. 3 to 4 months after injection, analysis was carried out with CD45.1-and CD45.2-specific antibodies to determine the contribution of donor-derived cells; frequency and fold differences were calculated with L-calc software (Stem Cell Technologies).
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The Affymetrix microarray data are available in the Gene Expression Omnibus (GEO) database under the accession number GSE21700. 
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